Loading data
ARWRNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 829.45 m USD | 3.55 m USD | 240.74 m USD | 243.23 m USD |
| Research and development expense | 607.16 m USD | 505.87 m USD | 353.19 m USD | — |
| Operating profit | 98.35 m USD | -601.08 m USD | -205 m USD | -178.51 m USD |
| Interest expense | — | — | 18.33 m USD | 0 USD |
| Profit before tax | 51.53 m USD | -612.46 m USD | -206.49 m USD | -172.71 m USD |
| Income tax expense | 21.42 m USD | -2.77 m USD | 2.78 m USD | 3.79 m USD |
| Net income (reported basis) | -1.63 m USD | -599.49 m USD | -205.28 m USD | -176.06 m USD |
| Basic earnings per share | -0.01 USD/share | -5 USD/share | -1.92 USD/share | -1.67 USD/share |
| Diluted earnings per share | -0.01 USD/share | -5 USD/share | -1.92 USD/share | -1.67 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.